BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Activity

7 hedge funds and large institutions have $938K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
–
Calls
$43K
Puts
$16K
Net Calls
+$27K
Net Calls Change
+$27K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$458K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$367K
3
TRCT
3
Tower Research Capital (TRC)
New York
$33K
4
UBS Group
4
UBS Group
Switzerland
$73.5K
5
Osaic Holdings
5
Osaic Holdings
Arizona
$1.02K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
1
Citadel Advisors
Florida
$458K 22,582 +22,582 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$367K 18,097 +18,097 New
UBS Group
3
UBS Group
Switzerland
$73.5K 3,624 +1,260 +53%
TRCT
4
Tower Research Capital (TRC)
New York
$33K 1,631 +1,631 New
Morgan Stanley
5
Morgan Stanley
New York
$3.06K 151 +44 +41%
Citigroup
6
Citigroup
New York
$1.73K 85 – –
Osaic Holdings
7
Osaic Holdings
Arizona
$1.02K 50 +50 New
CFGS
8
Concourse Financial Group Securities
Alabama
– – – –